Philip Vickers
Directeur/Bestuurslid bij AVROBIO, INC.
Vermogen: 5 688 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Erik Ostrowski | M | 51 | 5 jaar | |
| Mark Foley | M | 58 | 7 jaar | |
| Ian Clark | M | 62 | 7 jaar | |
| Philip Donenberg | M | 63 | 6 jaar | |
| Azadeh Golipour | M | - | 8 jaar | |
| John Pribis | M | - |
Solu Therapeutics
 Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Dwight Moxie | M | 48 | 4 jaar | |
| Christian Nolet | M | 67 | 5 jaar | |
| Vladimir Coric | M | 53 | 1 jaar | |
| Tobin Schilke | M | 49 | 6 jaar | |
| Christopher Paige | M | 71 | 8 jaar | |
| Olivia Ware | F | 67 | 3 jaar | |
| Steven Avruch | M | 63 | 5 jaar | |
| Carey Kolaja | F | 51 | 3 jaar | |
| Brandon Turunen | M | - |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Jerel Davis | M | 47 |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.
Northern Mosaic LP
 Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | 6 jaar |
| Annalisa Jenkins | M | 58 | 6 jaar | |
| Julian Gangolli | M | 66 | 8 jaar | |
| Jill Beraud | F | 63 | 5 jaar | |
| Bruce Booth | M | 49 | 8 jaar | |
| Gail Farfel | M | 60 | 4 jaar | |
| Bradly G. Wouters | M | - |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | - |
| Scott Gottesman | M | - | - | |
| Kirsten Dupuis | F | - | 8 jaar | |
| Peter Hutt | M | 89 |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Essra Ridha | M | 41 | 3 jaar | |
| Satoshi Konagai | M | - |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| John Hamer | M | 66 |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Enda Moran | M | - |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | 6 jaar |
| Christoph Westphal | M | 56 |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Bradley Bolzon | M | 64 |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | - |
| Leslie Waltke | F | - | 12 jaar | |
| Conor Gallagher | M | - | 6 jaar | |
| Joan Seoane Suarez | M | - |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | - |
| Omar Khalil | M | - |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | 1 jaar |
| David Hollander | M | 50 | 2 jaar | |
| Anita Treohan | F | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| L. Daniel Browne | M | 62 | 20 jaar | |
| Geoff MacKay | M | 57 | 8 jaar | |
| Graham Hetherington | M | 65 | 6 jaar | |
| Aubrey Rankin | M | - | 2 jaar | |
| Scott Applebaum | M | 57 | 2 jaar | |
| Kim Warren | M | - | 5 jaar | |
| Susan Kilsby | F | 65 | 8 jaar | |
| James Bowling | M | 56 | 10 jaar | |
| Angus Russell | M | 68 | 14 jaar | |
| Dustin Sjuts | M | 45 | 6 jaar | |
| Cyril Allouche | M | 52 | 2 jaar | |
| Deanna M. Petersen | F | 62 | 14 jaar | |
| William R. Mordan | M | 54 | 4 jaar | |
| S. Mathew | F | 68 | 4 jaar | |
| Jacob M. Waugh | M | 53 | 16 jaar | |
| Douglas Kerr | M | 57 |
Faze Medicines, Inc. /MA)
 Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA. | 5 jaar |
| Dominic Blakemore | M | 54 | 4 jaar | |
| David Altarac | M | 63 | - | |
| Ludovic Robin | M | - | 8 jaar | |
| Ian Karp | M | - | 5 jaar | |
| Jeanie D. Herbert | F | - | 6 jaar | |
| Christoph Brackmann | M | - | - | |
| Flemming Ørnskov | M | 66 | 6 jaar | |
| Mark Prygocki | M | 58 | 3 jaar | |
| Lauren Silvernail | F | 65 | 5 jaar | |
| Matthew Emmens | M | 72 | 11 jaar | |
| Phyllis Gardner | M | 73 | 15 jaar | |
| Abhay Joshi | M | 61 | 7 jaar | |
| Christopher Mason | M | 66 | 7 jaar | |
| Gail Fosler | F | 76 | 3 jaar | |
| Albert P. L. Stroucken | M | 76 | 3 jaar | |
| Steven Gillis | M | 71 | 7 jaar | |
| David Stout | M | 70 | 6 jaar | |
| Ronald Eastman | M | 71 | 8 jaar | |
| Robert F. Byrnes | M | 79 | 17 jaar | |
| David John Kappler | M | 76 | 12 jaar | |
| James Walter Glasheen | M | 56 | 12 jaar | |
| Caryn McDowell | F | 54 | - | |
| Susanne Fors | F | - | 1 jaar | |
| Barry M. Deutsch | M | 61 | 1 jaar | |
| Nawal Ouzren | F | 45 | 1 jaar | |
| Sotirios G. Stergiopoulos | M | 52 | - | |
| Debra Silberg | M | - | - | |
| Gisele Dion | F | 57 | 3 jaar | |
| Daryl DeKarske | M | - | 7 jaar | |
| Matthew Walker | M | 60 | - | |
| Gwendolyn Fisher | F | - | 96 jaar | |
| Thomas P. Mcdonnell | M | 52 | 2 jaar | |
| Justin Ford | M | - | 6 jaar | |
| Todd Zavodnick | M | 52 | 1 jaar | |
| Roman Rubio | M | 53 | 5 jaar | |
| Iain Ward | M | - | 8 jaar | |
| Perry Sternberg | M | 55 | 6 jaar | |
| Arthur Tzianabos | M | 60 | 8 jaar | |
| Sheila E. Stranks | F | - | 13 jaar | |
| Ann Powell | F | 58 | 4 jaar | |
| Michele Galen | F | 67 | 1 jaar | |
| David Colpman | M | 62 | 15 jaar | |
| Andrea Hunt | F | 64 | 1 jaar | |
| Erica Bazerkanian | F | - | 4 jaar | |
| Patrick J. Langlois | M | 78 | 6 jaar | |
| Jeffrey Leiden | M | 68 | 6 jaar | |
| Miguel Coego Rios | M | - | 8 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 55 | 55.00% |
| Ierland | 43 | 43.00% |
| Canada | 5 | 5.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Philip Vickers
- Persoonlijk netwerk
